Cart
sales@molnova.com
Sodium montmorillonite
CAS No. 1318-93-0
Sodium montmorillonite( —— )
Catalog No. M11290 CAS No. 1318-93-0
The montmorillonite-catalyzed reactions of the 5'-phosphorimidazolide of adenosine used as a model generated RNA type oligomers.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 45 | In Stock |
|
| 100MG | 65 | In Stock |
|
| 1G | 78 | In Stock |
|
Biological Information
-
Product NameSodium montmorillonite
-
NoteResearch use only, not for human use.
-
Brief DescriptionThe montmorillonite-catalyzed reactions of the 5'-phosphorimidazolide of adenosine used as a model generated RNA type oligomers.
-
DescriptionThe montmorillonite-catalyzed reactions of the 5'-phosphorimidazolide of adenosine used as a model generated RNA type oligomers.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1318-93-0
-
Formula Weight282.21
-
Molecular FormulaAl2O9Si3
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESO.[O--].[O--].[O--].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Joshi PC, Aldersley MF. J Mol Evol. 2013 Jun;76(6):371-9
molnova catalog
related products
-
Pelargonidin3-O-[6-O...
Pelargonidin3-O-[6-O-(E)-Ferulyl-2-O-{6-O-(E)-Ferulyl-β-D-glucoside}-β-D-glucoside]-5-O-(6-O-malonyl)-β-D-glucoside
-
HLM006474
HLM006474 is a pan inhibitor of E2F. This inhibits E2F4 DNA-binding (IC50: 29.8 μM in A375 cells).HLM006474 causes the viability of both SCLC and NSCLC lines (IC50 ranging from 15 to 75 μM). HLM006474 displays little activities against E2F4 DNA-binding in A375 cells at 10 and 20 μM, apparently inhibits E2F4 DNA-binding at 40 μM, and increasingly suppresses the effect at 60 and 80 μM concentrations.
-
Dasatinib carbaldehy...
Dasatinib carbaldehyde (PROTAC ABL binding moiety 4) is based on Dasatinib which is an ABL inhibitor, binds to the IAP ligand via a linker, and forms SNIPER .
